PSMA-ALB-56 - CAS# 2306049-48-7 Catalog No.:M16929-C Treatment of rats with 600

Treatment of rats with 600 μmol/kg of AR-M 1000390 results in vacuolation of the β-cell of the rat pancreas that is similar to that reported for cyclizine and cyproheptadine

a receptor tyrosine kinase that mediates tumor cell proliferation and migration and angiogenesis

1-10 mg/kg) increases vertebral blood flow in a dose-related manner and the effect is partially inhibited by Aminophylline (HY-B0140) in dogs[1]

was administered to Swiss-Webster mice at doses of 0

Smiles: CC1(C)[C@@H]2CC[C@]3(C)[C@H](CC[C@]45OC[C@@]6(CC[C@@](C)(C[C@H]64)C=O)[C@H](O)C[C@@]35C)[C@@]2(C)CC[C@@H]1O[C@@H]1OC[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

PSMA-ALB-56 - CAS# 2306049-48-7 Catalog No.:M16929-C Treatment of rats with 600PSMA ALB 56 is a PSMA targeting radioligand designed by combining the glutamate urea PSMA binding entity and an albumin binder. Product information CAS Number: 2306049 48 7 Molecular Weight: 1330. 52 Formula: C66H95N11O18 Chemical Name: (((S) 1 carboxy 5 ((S) 3 (naphthalen 2 yl) 2 ((1S, 4S) 4 (((S) 6 (4 (p tolyl)butanamido) 2 (2 (4, 7, 10 tris(carboxymethyl) 1, 4, 7, 10 tetraazacyclododecan 1 yl)acetamido)hexanamido)methyl)cyclohexane 1